AVALO THERAPEUTICS, INC. Cost of Revenue
AVALO THERAPEUTICS, INC. (AVTX) reported Cost of Revenue of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2025-08-07
- AVALO THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2024-09-30 was -$714.00K, a 389.07% decline year-over-year.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2024-06-30 was $343.00K, a 51.55% decline year-over-year.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2024-03-31 was -$80.00K, a 114.52% decline year-over-year.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for fiscal 2023 was $1.28M, a 62.61% decline from fiscal 2022.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for fiscal 2022 was $3.43M, a 130.32% increase from fiscal 2021.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for fiscal 2021 was $1.49M, a 397.00% increase from fiscal 2020.
- AVALO THERAPEUTICS, INC. cost of goods and services sold for fiscal 2020 was $300.00K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | ||||||
| 2024-09-30 | -$714.00K 10-Q · filed 2024-11-07 | -$371.00K derived: sum of 2 quarters · filed 2025-08-07 | -$453.00K 10-Q · filed 2024-11-07 | -$672.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-06-30 | $343.00K 10-Q · filed 2025-08-07 | $263.00K 10-Q · filed 2025-08-07 | $42.00K derived: sum of 3 quarters · filed 2025-08-07 | $289.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$80.00K 10-Q/A · filed 2024-07-11 | -$301.00K derived: sum of 2 quarters · filed 2024-07-11 | -$54.00K derived: sum of 3 quarters · filed 2024-11-07 | $654.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-12-31 | -$221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $26.00K derived: sum of 2 quarters · filed 2024-11-07 | $734.00K derived: sum of 3 quarters · filed 2024-11-07 | $1.28M 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | $247.00K 10-Q · filed 2024-11-07 | $955.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.50M 10-Q · filed 2024-11-07 | $2.13M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $708.00K 10-Q · filed 2024-08-12 | $1.26M 10-Q · filed 2024-08-12 | $1.88M derived: sum of 3 quarters · filed 2024-08-12 | $2.41M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $551.00K 10-Q/A · filed 2024-07-11 | $1.17M derived: sum of 2 quarters · filed 2024-07-11 | $1.70M derived: sum of 3 quarters · filed 2024-07-11 | $3.27M derived: sum of 4 quarters · filed 2024-07-11 | ||||
| 2022-12-31 | $620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.15M derived: sum of 2 quarters · filed 2024-03-29 | $2.71M derived: sum of 3 quarters · filed 2024-03-29 | $3.43M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $528.00K 10-Q · filed 2023-11-09 | $2.10M derived: sum of 2 quarters · filed 2023-11-09 | $2.81M 10-Q · filed 2023-11-09 | $3.24M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $1.57M 10-Q · filed 2023-08-03 | $2.29M 10-Q · filed 2023-08-03 | $2.71M derived: sum of 3 quarters · filed 2023-08-03 | $3.62M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $720.00K 10-Q · filed 2023-05-04 | $1.14M derived: sum of 2 quarters · filed 2023-05-04 | $2.05M derived: sum of 3 quarters · filed 2023-05-04 | $2.13M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.33M derived: sum of 2 quarters · filed 2023-03-29 | $1.42M derived: sum of 3 quarters · filed 2023-03-29 | $1.49M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $908.00K 10-Q · filed 2022-11-07 | $991.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.07M 10-Q · filed 2022-11-07 | $1.15M derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $83.00K 10-Q · filed 2022-08-04 | $159.00K 10-Q · filed 2022-08-04 | $239.00K derived: sum of 3 quarters · filed 2022-08-04 | $316.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $77.00K 10-Q · filed 2022-05-05 | $156.00K derived: sum of 2 quarters · filed 2022-05-05 | $233.00K derived: sum of 3 quarters · filed 2022-05-05 | $311.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $156.00K derived: sum of 2 quarters · filed 2022-03-02 | $234.00K derived: sum of 3 quarters · filed 2022-03-02 | $300.00K 10-K · filed 2022-03-02 | $300.20K 10-K · filed 2021-03-08 | |||
| 2020-09-30 | $77.00K 10-Q · filed 2021-11-09 | $76.64K 10-Q · filed 2020-11-09 | $155.00K derived: sum of 2 quarters · filed 2021-11-09 | $221.00K 10-Q · filed 2021-11-09 | $220.78K 10-Q · filed 2020-11-09 | -$3.59M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $78.00K 10-Q · filed 2021-08-02 | $77.58K 10-Q · filed 2020-08-06 | $144.00K 10-Q · filed 2021-08-02 | $144.14K 10-Q · filed 2020-08-06 | -$3.66M derived: sum of 3 quarters · filed 2021-08-02 | -$3.53M derived: sum of 4 quarters · filed 2021-08-02 | ||
| 2020-03-31 | $66.00K 10-Q · filed 2021-05-13 | $66.56K 10-Q · filed 2020-05-07 | -$3.74M derived: sum of 2 quarters · filed 2021-05-13 | -$3.61M derived: sum of 3 quarters · filed 2021-05-13 | -$5.11M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$3.68M derived: sum of 2 quarters · filed 2020-11-09 | -$5.17M derived: sum of 3 quarters · filed 2020-11-09 | -$566.52K 10-K · filed 2020-03-11 | ||||
| 2019-09-30 | $132.38K 10-Q · filed 2020-11-09 | $1.44M 10-Q · filed 2019-11-14 | -$1.36M derived: sum of 2 quarters · filed 2020-11-09 | $3.24M 10-Q · filed 2019-11-14 | -$2.75M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$1.50M 10-Q · filed 2020-08-06 | -$141.82K 10-Q · filed 2019-08-08 | -$744.13K 10-Q · filed 2020-08-06 | $1.81M 10-Q · filed 2019-08-08 | -$2.88M derived: sum of 3 quarters · filed 2020-08-06 | $229.96K derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $752.55K 10-Q · filed 2020-05-07 | $1.95M 10-Q · filed 2019-05-09 | -$1.38M derived: sum of 2 quarters · filed 2020-05-07 | $1.73M derived: sum of 3 quarters · filed 2020-05-07 | $3.15M derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $974.09K derived: sum of 2 quarters · filed 2020-03-11 | $2.40M derived: sum of 3 quarters · filed 2020-03-11 | $3.26M 10-K · filed 2020-03-11 | $7.48M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $3.11M 10-Q · filed 2019-11-14 | $4.53M derived: sum of 2 quarters · filed 2019-11-14 | $5.40M 10-Q · filed 2019-11-14 | $6.03M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $1.42M 10-Q · filed 2019-08-08 | $2.29M 10-Q · filed 2019-08-08 | $2.92M derived: sum of 3 quarters · filed 2019-08-08 | $2.92M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $863.62K 10-Q · filed 2019-05-09 | $1.50M derived: sum of 2 quarters · filed 2019-05-09 | $1.50M derived: sum of 3 quarters · filed 2019-05-09 | $1.50M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $635.65K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $635.65K derived: sum of 2 quarters · filed 2019-03-18 | $635.65K derived: sum of 3 quarters · filed 2019-03-18 | $635.65K 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |